Abnormalities in the expression of cytokines and their receptors in patients with myelodysplastic syndromes.

被引:0
|
作者
FontenayRoupie, M
Dreyfus, F
机构
来源
PATHOLOGIE BIOLOGIE | 1997年 / 45卷 / 07期
关键词
cytokines; receptors;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Abnormalities of the expression of cytokines and their receptors seen in myelodysplastic syndromes (MDS) are reviewed. Autocrine and paracrine secretion of growth factors, most notably GM-CSF and IL-6, has been identified as a factor in clone expansion in young pediatric patients with chronic myelomonocytic leukemia. Mutations affecting cFMS, the receptor for M-CSF, have also been demonstrated. The other reported abnormalities have been found in too small a number of cases to explain the cell growth and differentiation disorders seen during the course of MDS. It remains possible, however, that a more detailed study of signal transduction pathways might detect functional abnormalities explaining the contrast between the small number of reported cases with abnormalities at the cytokine and cytokine receptor sites and the cell growth and differentiation disorders that are prominent in MDS.
引用
收藏
页码:569 / 572
页数:4
相关论文
共 50 条
  • [21] Telomere length in myelodysplastic syndromes.
    Boultwood, J
    Fidler, C
    Wainscoat, JS
    BLOOD, 1995, 86 (10) : 1325 - 1325
  • [22] Etiologic factors of myelodysplastic syndromes.
    Nisse, C
    PATHOLOGIE BIOLOGIE, 1997, 45 (07): : 539 - 544
  • [23] Prognostic classification in myelodysplastic syndromes.
    Sanz, GF
    Morel, P
    PATHOLOGIE BIOLOGIE, 1997, 45 (08): : 617 - 626
  • [24] Editorial. Myelodysplastic syndromes.
    Fenaux, P
    PATHOLOGIE BIOLOGIE, 1997, 45 (07): : 537 - 538
  • [25] Treatment strategy for myelodysplastic syndromes.
    Fenaux, P
    PATHOLOGIE BIOLOGIE, 1997, 45 (08): : 668 - 670
  • [26] Mechanisms of Disease: Myelodysplastic Syndromes.
    Tefferi, Ayalew
    Vardiman, James W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (19): : 1872 - 1885
  • [27] Psychological distress in myelodysplastic syndromes.
    Vallely, Jaxon
    Troy, Jesse D.
    Locke, Susan C.
    LeBlanc, Thomas William
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] Evaluation of cellular proliferation markers in patients with myelodysplastic syndromes.
    Ismail, SO
    Mutema, G
    Perrotta, G
    Hornback, B
    Wibowo, A
    Mazzella, F
    KowalVern, A
    Schumacher, HR
    BLOOD, 1997, 90 (10) : 4040 - 4040
  • [29] Paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes.
    Iwanaga, M
    Furukawa, K
    Amenomori, T
    Mori, H
    Nakamura, H
    Fuchigami, K
    Kamihira, S
    Nakakuma, H
    Tomonaga, M
    BLOOD, 1997, 90 (10) : 2708 - 2708
  • [30] Intensive chemotherapy in myelodysplastic syndromes.
    Dombret, H
    PATHOLOGIE BIOLOGIE, 1997, 45 (08): : 627 - 635